Bill Maher insider trades: abrdn Life Sciences Investors (HQL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bill reports to the SEC
and 4 more companies
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | HQL | ↑ Buy | 650 | $15.37 | $10K | By Spouse | Aug 27, 2024 (4d) |
| Aug 23, 2024 | AEF | ↑ Buy | 931 | $5.37 | $5K | By Spouse | Aug 27, 2024 (4d) |
| Aug 23, 2024 | JEQ | ↑ Buy | 809 | $6.17 | $5K | By Spouse | Aug 27, 2024 (4d) |
| Aug 14, 2024 | VFL | ↑ Buy | 2,000 | $10.99 | $22K | Direct | Aug 16, 2024 (2d) |
| Aug 14, 2024 | THW | ↑ Buy | 1,000 | $13.03 | $13K | Direct | Aug 16, 2024 (2d) |
| Aug 14, 2024 | JEQ | ↑ Buy | 1,000 | $5.90 | $6K | Direct | Aug 16, 2024 (2d) |
| Aug 14, 2024 | AEF | ↑ Buy | 1,000 | $5.25 | $5K | Direct | Aug 16, 2024 (2d) |
| Dec 28, 2023 | THQ | ↑ Buy | 1,000 | $18.25 | $18K | Direct | Jan 2, 2024 (5d) |
| Dec 28, 2023 | HQH | ↑ Buy | 1,000 | $16.58 | $17K | Direct | Jan 2, 2024 (5d) |
| Dec 28, 2023 | HQL | ↑ Buy | 1,000 | $13.57 | $14K | Direct | Jan 2, 2024 (5d) |
| Dec 28, 2023 | VFL | ↑ Buy | 1,000 | $10.19 | $10K | By Self as Owner of Maher/Goldhammer Rev | Jan 2, 2024 (5d) |
| Jul 10, 2023 | JEQ | ↑ Buy | 1,500 | $5.84 | $9K | By Self as Owner of Maher/Goldhammer Rev | Jul 12, 2023 (2d) |
| Apr 22, 2021 | AEF | ↑ Buy | 7,000 | $8.59 | $60K | Direct | Apr 26, 2021 (4d) |
| Apr 20, 2021 | AEF | ↓ Sell | 7,000 | $8.59 | $60K | Direct | Apr 21, 2021 (1d) |
| Apr 19, 2021 | AEF | ↑ Buy | 7,000 | $8.68 | $61K | Direct | Apr 21, 2021 (2d) |
| Feb 1, 2017 | GCH | ↑ Buy | 4,000 | $9.21 | $37K | Direct | Feb 2, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other HQL insiders
Open-market trades in the last 12 months
About Bill Maher's insider trades
Bill Maher is a director at abrdn Life Sciences Investors (HQL). Since Feb 1, 2017, Bill has reported 15 open-market purchases worth $291K and 1 sale worth $60K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (5 filings), shares returned to the company (1 filing), option exercises (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HQL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.